4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Surrozen, Inc. (SRZN) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 44 employees. Its market capitalization is roughly $273 million. In the fiscal year ended 2025-12-31, SRZN reported $4M in revenue and ($242M) in net income.
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair.
Interactive charts & full statements → Open the SRZN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $4M | $11M | $0M | $12M |
| Operating Income (EBIT) | ($42M) | ($26M) | ($43M) | ($44M) |
| Net Income | ($242M) | ($64M) | ($43M) | ($36M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $5M | $0M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($10M) | ($13M) | ($11M) | ($9M) | ($10M) | — |
| Net Income | ($128M) | ($183M) | ($72M) | $40M | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $99M | $48M | $46M | $89M | — |
| Total Liabilities | $286M | $70M | $8M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SRZN viewer.
About TickerBase · Data methodology & sources